Navigation Links
Viscira Announces Version 2.0 of its Online Interactive Slide Kit Builder Application
Date:6/15/2010

Company releases an upgraded SaaS application for the life sciences industry that incorporates distinctive features and functionality

(PRWEB) June 15, 2010 -- Viscira™, a leading provider of interactive and new-media solutions for the life sciences industry, today announced the release of Version 2.0 of its Interactive Slide Kit Builder application for pharmaceutical, biotech, and medical device customers. Viscira’s web-based software platform provides users with the ability to create and save custom presentations using approved slides through an intuitive graphical user interface.

Some of the many robust features included with the upgraded application are as follows:

 
  • The ability to quickly create and save custom presentations in multiple delivery formats including PowerPoint, PDF, Flash, and other enhanced, new-media formats.
  • Embedded programming logic which can require users to use certain slides in combination and include specific mandatory slides.
  • Customizable access levels which allow specific users to view only certain slide groupings and perform only designated functions.
  • The ability to publish any slide updates to all saved presentation slide decks in real time.
  • A full companion administrative tool enabling authorized users to add/delete users, upload new slide decks, send notifications, and generate reports.

The Viscira Interactive Slide Kit Builder is a secure, web-based platform with a flexible technology architecture that has been designed to maximize functionality and ease-of-use for users. It can be seamlessly integrated into an existing client website or speaker extranet, and can be tailored to comply with specific customer workflow and regulatory compliance requirements. It can also be delivered as a stand-alone, offline application.

“Our new Interactive Slide Kit Builder product incorporates next-generation technology and many innovative features that provide significant benefit to life science companies and their product speakers beyond current industry offerings”, explains Dave Gulezian, President and CEO of Viscira. “It also offers our customers expanded presentation flexibility, while maintaining their adherence to pharma regulatory guidelines and industry best practices.”

To schedule a review and demonstration of the Viscira Interactive Slide Kit Builder application, please contact the company at 415-848-8010 or send an email to sales@viscira.com.

This product is just one of many innovative interactive and new-media solutions the company offers, which range from 3D mechanism of action animations to enhanced KOL video presentation modules to interactive sales aids. Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis.

About Viscira
Viscira is dedicated to the development of new-media communication solutions and interactive software applications for the life sciences industry. Viscira provides a suite of programs that provide best-in-class technology solutions to deliver engaging and memorable content via various electronic channels. For more information, please visit the company’s website at www.viscira.com or contact Noel Ashekian at (617) 429-0834.

Press Contact
Noel Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834

###

Read the full story at http://www.prweb.com/releases/SaaSapplication/lifesciences/prweb4131114.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Looking at AMD Through Patients' Eyes: Viscira Virtual Exhibit Educates Physicians by Personalizing Serious Eye Disease
2. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
3. Novavax Announces Manufacturing Management Appointments
4. Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
5. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
6. China Medicine Announces Results of Annual Meeting of Stockholders
7. Oncothyreon announces presentations at upcoming investor conferences in June
8. PregLem Announces Positive Phase III Results for Esmya(TM)
9. Dendreon Announces Election of Dr. David C. Stump to Board of Directors
10. Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results
11. Huiheng Medical, Inc. Announces Agreement to Acquire the ClearPath (TM) Breast Brachytherapy System
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viscira Announces Version 2.0 of its Online Interactive Slide Kit Builder Application 
(Date:12/2/2016)... ... , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility ... Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will ... Zurich to discuss the benefits of a viscoelastic disc. AxioMed received CE mark ...
(Date:12/2/2016)... -- The Multiple Myeloma Research Foundation (MMRF) today announced that ... —the largest and most comprehensive study driving new genomic ... presented at the 58 th American Society of ... San Diego from December 3-6. The new ... as identify pathways and targets for new drug development. ...
(Date:12/2/2016)... 2016 CytRx Corporation (NASDAQ: CYTR ... oncology, today announced the appointment of Earl Warren ... and private healthcare investor, to its Board of Directors. ... clinical and strategic experience at the highest level," said ... "As one of the world,s leading orthopedic surgeons, Dr. ...
(Date:12/2/2016)... Diego, CA (PRWEB) , ... December 01, 2016 , ... ... data from its Phase I/II clinical trials for AC0010 at the World Conference on ... forward to providing an update on the phase I/II clinical trials for AC0010 in ...
Breaking Biology Technology:
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
Breaking Biology News(10 mins):